Infectious mononucleosis diagnosis in young adults
Answer
The diagnosis of infectious mononucleosis (IM) in young adults is primarily based on clinical and laboratory findings
Clinical presentation
- Age group: IM is most frequently observed in adolescents and young adults, with a peak incidence between ages 15-24 years
- Symptoms: Patients typically present with sore throat, significant fatigue, palatal petechiae, posterior cervical or auricular lymphadenopathy, marked axillary lymphadenopathy, or inguinal lymphadenopathy
- Complications: Complications can include hematological issues (e.g., hemolytic anemia, thrombocytopenia), neurologic complications (e.g., Guillain-Barre syndrome, facial paralysis), splenic rupture, airway obstruction, pneumonia, and hemophagocytic lymphohistiocytosis
Laboratory findings
- EBV infection: IM is most frequently caused by the Epstein-Barr virus (EBV), transmitted through infected saliva
- HLA class I polymorphisms: Certain HLA class I polymorphisms may predispose patients to the development of IM upon primary EBV infection
Differential diagnosis
- Lymphoma: The morphological features of EBV-infected lymphoid tissue can mimic lymphoma, necessitating careful differentiation
- Multiple sclerosis (MS): IM in childhood and adolescence is associated with an increased risk of a subsequent MS diagnosis, independent of shared familial factors
Prognosis
- Recovery: Most patients achieve complete resolution within weeks, and mortality rates are low (5.3%)
- Chronic fatigue syndrome (CFS): IM may be a risk factor for CFS in adolescents, with female gender and greater fatigue severity associated with the development of CFS
In conclusion, the diagnosis of IM in young adults is based on a combination of clinical presentation and laboratory findings, with careful consideration of differential diagnoses. The prognosis is generally favorable, although complications can occur.